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Hemorrhagic fever with renal syndrome (HFRS) is an acute viral disease with fever,
hemorrhage and renal failure caused by hantavirus infection. Hantavirus induces
HFRS or hantavirus pulmonary syndrome (HPS). HPS progression to a life-
threatening pulmonary disease is found primarily in the USA and very rarely in
South Korea. Here, we report a case of HFRS and coexisting HPS.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Hantavirus comprises a genus of envelope viruses within the
family Bunyaviridae. Infection with hantavirus may induce
hemorrhagic fever with renal syndrome (HFRS) or hantavirus
pulmonary syndrome (HPS). HFRS is not an uncommon disease
in Korea and has several prominent features including fever,
hemorrhage, hypotension and renal failure. Hantaan virus,
which is usually associated with HFRS in Korea, may lead to
more severe HFRS than any other strain [1]. Patients with severe
HFRS typically progress sequentially from fever to abrupt
hypotension and clinical shock, and then to oliguria. As throm-
bocytopenia and DIC develop, ﬁndings of diffuse hemorrhage
may appear. Patients subsequently enter a diuretic phase and
then a convalescent phase that often lasts for many weeks.
Pulmonary manifestations are prominent ﬁnding in HPS and in
epidemics in the USA. The mortality rate for patients with severe
HFRS has decreased to o5% with advanced supportive care.rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
rnal Medicine, Chonbuk
Keum-Am dong, Jeonju,However, HPS can progress to a severe degree more frequently
than HFRS. To the best of our knowledge, there has only been
one published case of HFRS with coexisting HPS in Korea [2]. We
report on a 51-year-old man with HFRS and coexisting HPS who
completely recovered without complications.
Case report
A 51-year-old man was admitted complaining of fever and
petechiae over his entire body. He had visited family graves
10 day before presenting at our clinic. Three days prior to
admission, fever, myalgia, chills, and petechiae developed and
progressively worsened. He had a history of previous pulmon-
ary tuberculosis, but no history of diabetes mellitus, hyperten-
sion, or hepatitis. A physical examination revealed a patient
who appeared to be acutely ill, with a ﬂushed face and
petechiae over his entire body. He had mild dyspnea and
tachypnea. The vital signs on admission were as follows: blood
pressure, 100/60 mmHg; body temperature, 37.1 1C; pulse, 85
beats/minute; and respiratory rate, 24/minute. The laboratory
ﬁndings on admission were as follows: hemoglobin, 10.0 g/dL;
white blood cell count, 15.1109/L; platelet count, 12109/L;
blood urea nitrogen, 51 mg/dL; creatinine, 4.5 mg/dL; aspartateublished by Elsevier. This is an open access article under the CC BY-NC-
Figure 1. (A) On admission, a chest X-ray revealed pulmonary edema and hemorrhage. (B) Bronchoscopy showed a pulmonary hemorrhage
and mucosal swelling in both lungs.
Figure 2. The patient’s disease course. Unlike typical HFRS, there was
no prominent shock phase and the patient continued to receive
ventilatory care, antibiotics, platelet transfusions, and support for
disseminated intravascular coagulation as indicated.
Figure 3. After adequate treatment, a chest X-ray demonstrated the
absence of pulmonary hemorrhage.
YM Hong et al / HFRS and coexisting HPS 119transaminase, 952 IU/L; alanine transaminase, 513 IU/L; amy-
lase, 117 IU/L; lipase, 84 IU/L; creatine kinase, 2,155 IU/L; and
lactate dehydrogenase, 2614 IU/L. Urinalysis revealed a protei-
nuria of þ3, with ﬁve to nine erythrocytes and ﬁve to nine
leukocytes per high-power ﬁeld. Serum samples were tested for
serodiagnosis of HFRS using an immunoﬂuorescent antibody
test (SD Bioline, Korea) for detection of IgG, IgM, and IgA
antibodies to the hantavirus genus. Serologic tests were positive
for Hantaan virus and negative for leptospirosis and tsutsuga-
mushi. On his second day in hospital, the patient complained of
worsening dyspnea with hemoptysis and wheezing in both lung
ﬁelds. His oxygen saturation decreased to 66% according to
pulse oximetry, and he was placed on a ventilator. A chest X-ray
and portable bronchoscopy showed pulmonary hemorrhage in
both lungs (Fig. 1A and B). The follow-up laboratory ﬁndings
were suggestive of disseminated intravascular coagulation
(DIC), as follows: ﬁbrinogen, 525 mg/dL; ﬁbrin degradation
products, 71.9 g/mL; antithrombin III, 69.9%; D-dimer, 2129 g/
L; prothrombin time, international normalized ratio of 1.13; and
activated partial thromboplastin time, 83.1 seconds. He contin-
ued to receive ventilator care, antibiotics, platelet transfusions,
and support for DIC as indicated. Unlike typical HFRS, there was
no prominent shock phase (Fig. 2). His urine volume and
pulmonary hemorrhage gradually improved (Fig. 3). He was
discharged on Day 22 without complications.Discussion
Hantaviruses are the causative agents of HFRS and HPS,
and are widely distributed in Eurasia and North America.
Hantaviruses are rodent-borne and transmitted to humans by
direct contact with infected animals or their secretions, such
as urine, feces, and saliva. Increased vascular permeability
plays a general role in the pathogenesis of severe hantavirus
infection. The clinical course can be extremely variable, and
some infected patients are asymptomatic. Moreover, the
manifestations and local distribution of the illness depend
on the strain of the infecting virus [3–5]. HFRS occurs with
infections by Hantaan and Dobrava viruses, while Sin Nombre
and Andes viruses primarily induce HPS [1,6]. HFRS and
HPS share some clinical features, but hemorrhage and renal
failure are hallmarks of HFRS, while pulmonary problems are
Kidney Res Clin Pract 31 (2012) 118–120120distinctive signs and symptoms in patients with HPS. The
mortality rate for patients with severe HFRS has decreased to
o5% with advanced supportive care. However, HPS can
progress to a life-threatening condition more frequently than
HFRS. Patients with HPS, after a prodromal phase similar to
that of HFRS, very rapidly develop pulmonary edema and
shock, which often requires mechanical ventilation and/or
extracorporeal membrane oxygenation. The case fatality rate
is approximately 35% [7]. The basis of lung vascular leakage
during hantavirus infection, and ultimately HPS, is not well
understood. The progression to HPS is likely to be a multi-
factorial process with contributions directly from virus repli-
cation and indirectly from the immune response induced by
viral infection [8]. In this case, we did not recognize pulmon-
ary hemorrhage during the prodromal phase of the illness.
The prodromal phase was followed by cough and dyspnea,
and progressed to bronchorrhea and pulmonary hemorrhage.
However, after adequate ventilation and conservative treat-
ment, the patient had a complete recovery. This is a rare case
of HFRS caused by Hantaan virus that was manifest as
unusual pulmonary hemorrhage.Conﬂict of interest
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